# BUPIVACAINE HYDROCHLORIDE
> **ANDA217792** · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET · Approved 2023-11-20
## Drug
- **FDA Application Number:** ANDA217792
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUPIVACAINE HYDROCHLORIDE
- **Generic name:** BUPIVACAINE HYDROCHLORIDE
- **Active ingredients:** BUPIVACAINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SOMERSET
- **Manufacturer:** Somerset Therapeutics, LLC
- **First approval:** 2023-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217792)
---
*MORVS · CC0 1.0*